AMERICAN GLAUCOMA SOCIETY INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1985

Legal Domicile

Principal Officer

STEVEN J GEDDE MD

Phone

4155618587

Tax Period

2024-01-01 to 2024-12-31

AMERICAN GLAUCOMA SOCIETY INC, founded in 1985, is a community nonprofit in the Diseases & Disorders sector that reported $2.5M in total revenue in fiscal year 2024. Expenses of $2.4M left a modest 4% surplus.

Mission

AGS IS THE PREEMINENT ORGANIZATION DEDICATED TO IMPROVING THE LIVES OF ALL PEOPLE WITH GLAUCOMA AND THOSE AT RISK BY LEADING THE ADVANCEMENT OF EDUCATION, RESEARCH, HEALTH CARE ACCESS, AND ADVOCACY.

Program Service Accomplishments

Program 1

Expenses: $873,865 Revenue: $923,395

ANNUAL MEETING OF THE AMERICAN GLAUCOMA SOCIETY - THE AGS HOLDS AN ANNUAL SCIENTIFIC MEETING THAT DRAWS ON AVERAGE OF 950 GLAUCOMA PROFESSIONALS.

Program 2

Expenses: $200,000 Revenue: $0

RESEARCH GRANTS - AGS PROGRAMS INCLUDE AWARDING RESEARCH GRANTS TO YOUNG AND MID-CAREER PHYSICIAN SCIENTISTS; ON AVERAGE FOUR GRANTS ARE AWARDED. THE AGS ALSO HAS A MENTORING PROGRAM FOR THE...

RESEARCH GRANTS - AGS PROGRAMS INCLUDE AWARDING RESEARCH GRANTS TO YOUNG AND MID-CAREER PHYSICIAN SCIENTISTS; ON AVERAGE FOUR GRANTS ARE AWARDED. THE AGS ALSO HAS A MENTORING PROGRAM FOR THE ADVANCEMENT OF PHYSICIAN SCIENTISTS. THIS PROGRAM IS FUNDED BY A CORPORATE SUPPORTER OR A FOUNDATION AND ITS MISSION IS TO PROVIDE FINANCIAL AID TO YOUNG GLAUCOMATOLOGISTS TO OVERCOME BARRIERS IN THEIR EARLY CAREER PATH; SIX TO TEN AWARDS ARE GRANTED ANNUALLY DEPENDING ON FUNDING.

Program 3

Expenses: $120,453 Revenue: $0

OPHTHALMOLOGY GLAUCOMA - OPHTHALMOLOGY GLAUCOMA PROVIDES A STIMULATING FORUM FOR DISCUSSION OF CLINICAL, SCIENTIFIC, AND SOCIOECONOMIC ISSUES OF GREATEST CONCERN TO CLINICIANS WHO CARE FOR GLAUCOMA PATIENTS. EACH ISSUE PRESENTS ORIGINAL ARTICLES ON NEW APPROACHES TO DIAGNOSIS, INNOVATIONS IN PHARMACOLOGICAL THERAPY AND SURGICAL TECHNIQUE, AND BASIC SCIENCE ADVANCES THAT IMPACT CLINICAL PRACTICE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $743,500

Program Service Revenue $1,595,469

Investment Income $162,637

Other Revenue $19,250

TOTAL REVENUE $2,520,856

Expense Breakdown

Grants Paid $275,500

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,503,914

Other Expenses $2,141,403

TOTAL EXPENSES $2,416,903

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,520,856	$2,502,848	+0.0%
Expenses	$2,416,903	$2,241,755	+0.1%
Net Income	$103,953	$261,093	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

100

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LEON W HERNDON JR MD	PRES THRU 3/2024 / PAST PRESIDENT	1.00	Officer Director	$0	$0	$0
CARLA J SIEGFRIED MD	VP THRU 3/2024 / PRES START 3/2024	1.00	Officer Director	$0	$0	$0
STEVEN J GEDDE MD	VICE PRESIDENT START 3/2024	1.00	Officer Director	$0	$0	$0
DAVID G GODFREY MD	TREASURER	1.00	Officer Director	$0	$0	$0
JOANN A GIACONI MD	SECRETARY THRU 3/2024	1.00	Officer Director	$0	$0	$0
JOSHUA D STEIN MD MS	SECRETARY START 3/2024	1.00	Officer Director	$0	$0	$0
LAMA A AL-ASWAD MD MPH	MEMBER-AT-LARGE THRU 3/2024	1.00	Director	$0	$0	$0
GEOFFREY T EMERICK MD	PATIENT CARE COMMITTEE CHAIR	1.00	Director	$0	$0	$0
RONALD L FELLMAN MD	PAST PRESIDENT THRU 3/2024	1.00	Director	$0	$0	$0
ANN CAROLINE FISHER MD	DEI COMMITTEE CHAIR	1.00	Director	$0	$0	$0
CHRISTOPHER A GIRKIN MD MSPH	PAST PRESIDENT	1.00	Director	$0	$0	$0
YING HAN MD PHD	RESEARCH COMMITTEE CHAIR	1.00	Director	$0	$0	$0
SHIVANI S KAMAT MD	JR. MEMBER-AT-LARGE START 3/2024	1.00	Director	$0	$0	$0
MICHELE C LIM MD	PROGRAM COMMITTEE CHAIR THRU 3/2024	1.00	Director	$0	$0	$0
STEVEN L MANSBERGER MD MPH	LEAD AMBASSADOR START 3/2024	1.00	Director	$0	$0	$0
FELIPE A MEDEIROS MD PHD	BYLAWS/STRAT PLANNING COMM CHAIR	1.00	Director	$0	$0	$0
KELLY W MUIR MD	EDUCATION AND COMMUNICATION CHAIR	1.00	Director	$0	$0	$0
KOUROS NOURI-MAHDAVI MD MSC	PROGRAM COMMITTEE CHAIR START 3/2024	1.00	Director	$0	$0	$0
ROMA PATEL MD	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
DOUGLAS J RHEE MD	MEMBER-AT-LARGE THRU 3/2024	1.00	Director	$0	$0	$0
OLUWATOSIN U SMITH MD	MEMBER-AT-LARGE START 3/2024	1.00	Director	$0	$0	$0
SAMUEL SOLISH MD	COUNCILOR TO AAO	1.00	Director	$0	$0	$0
ANGELA V TURALBA MD MMS	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
THASARAT S VAJARANANT MD	LEAD AMBASSADOR THRU 3/2024	1.00	Director	$0	$0	$0
KATEKI VINOD MD	MEMBER-AT-LARGE THRU 3/2024	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,520,856	$2,416,903	$8,087,312	$103,953
2023	$2,502,848	$2,241,755	$7,490,622	$261,093
2022	$2,257,324	$2,104,943	$6,678,622	$152,381
2021	$2,018,629	$1,482,028	$7,562,216	$536,601
2020	$3,040,228	$2,244,326	$6,381,209	$795,902
2019	$2,242,129	$1,843,664	$6,333,371	$398,465
2018	$2,297,521	$1,596,574	$4,965,141	$700,947